1. Home
  2. FIVN vs HROW Comparison

FIVN vs HROW Comparison

Compare FIVN & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Five9 Inc.

FIVN

Five9 Inc.

HOLD

Current Price

$25.40

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$42.30

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIVN
HROW
Founded
2001
1998
Country
United States
United States
Employees
N/A
373
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
FIVN
HROW
Price
$25.40
$42.30
Analyst Decision
Buy
Strong Buy
Analyst Count
18
8
Target Price
$26.06
$69.86
AVG Volume (30 Days)
2.5M
796.4K
Earning Date
04-30-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
364.71
N/A
EPS
0.21
N/A
Revenue
$1,149,088,000.00
N/A
Revenue This Year
$11.39
$31.62
Revenue Next Year
$10.00
$50.77
P/E Ratio
$118.71
N/A
Revenue Growth
10.28
N/A
52 Week Low
$13.29
$28.54
52 Week High
$29.64
$54.98

Technical Indicators

Market Signals
Indicator
FIVN
HROW
Relative Strength Index (RSI) 67.76 54.82
Support Level $17.38 $40.56
Resistance Level $26.93 $44.50
Average True Range (ATR) 1.21 2.11
MACD 0.50 -0.07
Stochastic Oscillator 95.32 27.70

Price Performance

Historical Comparison
FIVN
HROW

About FIVN Five9 Inc.

Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Intelligent CX platform combines core telephony functionality, omnichannel engagement, and modules into a cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, and optimization solutions, as well as artificial intelligence-driven automation solutions that optimize customer service efficiency and manage interaction quality and agent performance.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: